Spectrum of enterovirus serotypes causing uncomplicated hand, foot, and mouth disease and enteroviral diagnostic yield of different clinical samples

<p>Background Hand, foot, and mouth disease (HFMD) represents a substantial disease burden in the Western Pacific region. We investigated the spectrum of causative enteroviruses of HFMD, and evaluated different clinical samples’ diagnostic yield for enteroviruses.</p> <p>Methods We...

Full description

Bibliographic Details
Main Authors: Gao, L, Zou, G, Liao, Q, Zhou, Y, Liu, F, Dai, B, Liu, J, Chen, Z, Xing, W, Yang, L, Liang, H, Zhang, Y, Luo, L, Li, Q, Luo, K, Wu, P, Mo, X, Wang, L, Lan, K, Horby, P, Cowling, B, Simmonds, P, Altmeyer, R, van Doorn, H, Yu, H
Format: Journal article
Language:English
Published: Oxford University Press 2018
Description
Summary:<p>Background Hand, foot, and mouth disease (HFMD) represents a substantial disease burden in the Western Pacific region. We investigated the spectrum of causative enteroviruses of HFMD, and evaluated different clinical samples’ diagnostic yield for enteroviruses.</p> <p>Methods We enrolled pediatric patients hospitalized for HFMD among 6 hospitals in Anhua County, Hunan Province, China between October 2013 and September 2016. Throat swabs and stool samples (or rectal swabs) were collected to detect the enterovirus serotypes by real-time reverse-transcription polymerase chain reaction (PCR) or nested PCR.</p> <p>Results Among the 2836 patients, only 1 developed severe illness. Seventeen serotypes were identified in 2401 patients (85%), with the most frequently detected being CV-A16 (29% [814]), CV-A6 (28% [784]), EV-A71 (17% [491]), CV-A10 (4% [114]), and CV-A4 (2% [53]). Children were younger in CV-A6, CV-A10, and CV-A4 infections (median, 12 months; interquartile range [IQR], 12–24 months) than EV-A71 and CV-A16 infections (median, 24 months; IQR, 12–36 months; P &lt; .05). The predominant enterovirus serotype shifted between CV-A16 and CV-A6 during the 3 years. Stool had a higher diagnostic yield (89%) than rectal (77%) and throat swabs (74%). Detection rates reached 93% when testing stools followed by throat swabs if stools were negative, and 89% when testing rectal swabs followed by throat swabs if rectal swabs were negative.</p> <p>Conclusions Our results provide a virological benchmark for future surveillance and diagnostics. Continuous comprehensive virological surveillance is essential, especially after implementation of the EV-A71 vaccine in China, to monitor serotype replacement and the vaccine’s impact.</p>